# LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

> **NCT01207947** · — · COMPLETED · sponsor: **Bayer** · enrollment: 491 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Vardenafil (Levitra, BAY38-9456)

## Key facts

- **NCT ID:** NCT01207947
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-06
- **Final completion:** 2010-03
- **Target enrollment:** 491 (ACTUAL)
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207947, "LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01207947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*